7Baggers
 Nektar Therapeutics enters $110 million equity distribution agreement  StreetInsider Wed, 12 Nov 2025 21:34:51 GMT
 Nektar Therapeutics: Cautiously Positive Moving Into Phase 2b Readout  Seeking Alpha Wed, 12 Nov 2025 05:39:06 GMT
 published on: 2025-11-11 19:59:22  newser.com Wed, 12 Nov 2025 01:59:22 GMT
 positive readouts validate pipelines, fuel drug developer rally  BioWorld MedTech Tue, 11 Nov 2025 17:00:00 GMT
 Nektar Therapeutics Reveals Promising Phase 2b Trial Results  TipRanks Mon, 10 Nov 2025 12:00:03 GMT
 nektar therapeutics reports new data from phase 2b rezolve-ad trial  TradingView Mon, 10 Nov 2025 11:35:00 GMT
 oppenheimer reiterates outperform rating on nektar therapeutics (nktr)  StreetInsider Mon, 10 Nov 2025 08:06:37 GMT
 nektar (nktr) highlights promising phase 2b study results for at  GuruFocus Sun, 09 Nov 2025 18:07:03 GMT
 Nektar Therapeutics (NASDAQ:NKTR) Q3 2025 Earnings Call Transcript  Insider Monkey Sat, 08 Nov 2025 13:15:19 GMT
 decoding nektar therapeutics (nktr): a strategic swot insight  GuruFocus Sat, 08 Nov 2025 05:25:07 GMT
 transcript : nektar therapeutics, q3 2025 earnings call, nov 06, 2025  MarketScreener Fri, 07 Nov 2025 21:20:16 GMT
 Nektar Therapeutics Q3 Loss Narrower Than Expected, Revenues Rise Y/Y  Zacks Investment Research Fri, 07 Nov 2025 14:31:06 GMT
 nektar therapeutics sec 10-q report  TradingView Fri, 07 Nov 2025 11:03:00 GMT
 nektar therapeutics reports q3 2025 financial results  TipRanks Fri, 07 Nov 2025 05:19:56 GMT
 earnings call transcript: nektar q3 2025 sees stock rise 1.57%  Investing.com Fri, 07 Nov 2025 01:06:46 GMT
 nektar therapeutics (nktr) reports q3 loss, beats revenue estimates  sharewise.com Fri, 07 Nov 2025 00:07:39 GMT
 earnings call transcript: nektar q3 2025 sees stock rise 1.57% by investing.com  Investing.com Canada Thu, 06 Nov 2025 23:52:48 GMT
 nektar: q3 earnings snapshot  NewsTimes Thu, 06 Nov 2025 22:46:08 GMT
 nektar therapeutics' q3 revenue drops after facility sale  MarketScreener Thu, 06 Nov 2025 22:43:26 GMT
 nektar therapeutics (nktr) tops q3 eps by 185c  StreetInsider Thu, 06 Nov 2025 22:17:25 GMT
 published on: 2025-11-06 05:38:51  Fundação Cultural do Pará Thu, 06 Nov 2025 08:38:51 GMT
 Nektar Therapeutics Reports Third Quarter 2025 Financial Results  PR Newswire Thu, 06 Nov 2025 08:00:00 GMT
 Nektar Therapeutics (NKTR) Reports Q3 Loss, Beats Revenue Estimates  Yahoo Finance Thu, 06 Nov 2025 08:00:00 GMT
 Nektar Therapeutics Reports Q3 2025 Financial Results  TipRanks Thu, 06 Nov 2025 08:00:00 GMT
 nektar therapeutics q3 2025 earnings preview  MSN Wed, 05 Nov 2025 23:16:40 GMT
 nektar therapeutics (nasdaq:nktr) shares down 9.5% - time to sell?  MarketBeat Tue, 04 Nov 2025 19:23:22 GMT
 published on: 2025-11-03 04:48:43  newser.com Mon, 03 Nov 2025 10:48:43 GMT

Nektar Therapeutics
(NASDAQ:NKTR) 

NKTR stock logo

Nektar Therapeutics, a biopharmaceutical company, researches and develops drug candidates for cancer and auto-immune disease in the United States. The company develops Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic...

Founded: 1990
Full Time Employees: 723
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends